Delivery Order SPE2DB22D3004-SPE2DB24FQQ67
Award Date
6/6/24
Potential Completion Date
6/7/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $50,533.02 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has a ceiling value of $4,300.51 and is a Firm Fixed Price Delivery Order type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,525.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. This delivery order is part of a broader Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with...
This federal contract award is for the procurement of XIFAXAN 550 MG TABLET 60S by the Defense Logistics Agency (DLA) from the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $25,706.83 and is a firm fixed price delivery order running through March 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the DLA. The company holds a...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription medication, to the Defense Logistics Agency (DLA). The $10,097.22 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 10, 2024, with a period of performance through July 11, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The award, valued at $58,310.36, is a Firm Fixed Price Delivery Order contract with a period of performance ending on February 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The $29,968.65 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a Delivery Order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $34,299.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 21, 2021, with a completion date of September 22, 2021. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET 60S to the U.S. Department of Defense's Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price of $1,391.76 and has an Ultimate Completion Date of June 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of XIFAXAN 550 MG TABLET UD 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $4,673.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...